EXANE DERIVATIVES

Q2 2018 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Corinne Fleck - head of Regulatory affairs and reportings.
Location
Paris, France
Holdings as of
June 30, 2018
Value $
$467M
Num holdings
647
Date filed
10/24/2018, 11:24 AM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q1 2018 - Oct 24, 2018
Next filing
Q3 2018 - Oct 24, 2018
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2018 Q2 - Restatement compared to 2018 Q1 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Corinne Fleck Head of Regulatory Affairs and reportings Paris, France 10/24/2018